Yuya Kunisaki

Dr. Yuya Kunisaki


Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 December 2023 in Bioengineering
Verified
Journal Article
Open access
PDF file
XSXiaoyu Song
Xiaoyu Song
YNYuma Nihashi
Yuma Nihashi
MYMasamichi Yamamoto
Masamichi Yamamoto
DSDaiki Setoyama
Daiki Setoyama
YKYuya Kunisaki
Yuya Kunisaki
YKYasuyuki S Kida
Yasuyuki S Kida
Pancreatic ductal adenocarcinoma (PDAC) is a refractory tumor with a poor prognosis, and its complex microenvironment is characterized by a fibrous interstitial matrix surrounding PDAC cells. Type I collagen is a major component of this interstitial matrix. Abundant type I collagen promotes its deposition and cross-linking to form a rigid and dense physical barrier, which limits drug penetration and immune cell infiltration and provides drug resistance and metabolic adaptations. In this study, to identify the physical effect of the stroma, type I collagen was used as a 3D matrix to culture Capan-1 cells and generate a 3D PDAC model. Using transcriptome analysis, a link between type I collagen-induced physical effects and the promotion of Capan-1 cell proliferation and migration was determined. Moreover, metabolomic analysis revealed that the physical effect caused a shift in metabolism toward a glycolytic phenotype. In particular, the high expression of proline in the metabolites suggests the ability to maintain Capan-1 cell proliferation under hypoxic and nutrient-depleted conditions. In conclusion, we identified type I collagen-induced physical effects in promoting Capan-1 cells, which cause PDAC progression, providing support for the role of dense stroma in the PDAC microenvironment and identifying a fundamental method for modeling the complex PDAC microenvironment.


11 March 2025 in Leukemia
Verified
Journal Article
Open access
PDF file
TNTomoko Nomiyama
Tomoko Nomiyama
DSDaiki Setoyama
Daiki Setoyama
IYIkumi Yamanaka
Ikumi Yamanaka
MSMasatoshi Shimo
Masatoshi Shimo
KMKohta Miyawaki
Kohta Miyawaki
YKYuya Kunisaki
Yuya Kunisaki

29 September 2023 in Communications Biology
Verified
Journal Article
Open access
PDF file
KNKentaro Nakashima
Kentaro Nakashima
YKYuya Kunisaki
Yuya Kunisaki
KHKentaro Hosokawa
Kentaro Hosokawa
KGKazuhito Gotoh
Kazuhito Gotoh
HYHisayuki Yao
Hisayuki Yao
FAFumio Arai
Fumio Arai
Protection of telomeres 1a (POT1a) is a telomere binding protein. A decrease of POT1a is related to myeloid-skewed haematopoiesis with ageing, suggesting that protection of telomeres is essential to sustain multi-potency. Since mesenchymal stem cells (MSCs) are a constituent of the hematopoietic niche in bone marrow, their dysfunction is associated with haematopoietic failure. However, the importance of telomere protection in MSCs has yet to be elucidated. Here, we show that genetic deletion of POT1a in MSCs leads to intracellular accumulation of fatty acids and excessive ROS and DNA damage, resulting in impaired osteogenic-differentiation. Furthermore, MSC-specific POT1a deficient mice exhibited skeletal retardation due to reduction of IL-7 producing bone lining osteoblasts. Single-cell gene expression profiling of bone marrow from POT1a deficient mice revealed that B-lymphopoiesis was selectively impaired. These results demonstrate that bone marrow microenvironments composed of POT1a deficient MSCs fail to support B-lymphopoiesis, which may underpin age-related myeloid-bias in haematopoiesis.

Verified
Journal Article
Open access
PDF file
XSXiaoyu Song
Xiaoyu Song
YNYuma Nihashi
Yuma Nihashi
YIYukiko Imai
Yukiko Imai
NMNobuhito Mori
Nobuhito Mori
NKNoritaka Kagaya
Noritaka Kagaya
YKYasuyuki S Kida
Yasuyuki S Kida
Pancreatic ductal adenocarcinoma (PDAC) is a solid-tumor malignancy. To enhance the treatment landscape of PDAC, a 3D model optimized for rigorous drug screening is essential. Within the PDAC tumor microenvironment, a dense stroma comprising a large extracellular matrix and cancer-associated fibroblasts (CAFs) is well-known for its vital role in modulating tumor growth, cellular heterogeneity, bidirectional paracrine signaling, and chemoresistance. In this study, we employed a fibroblast-populated collagen lattice (FPCL) modeling approach that has the ability to replicate fibroblast contractility in the collagenous matrix to build dense stroma. This FPCL model allows CAF differentiation by facilitating multifaceted cell–cell interactions between cancer cells and CAFs, with the differentiation further influenced by mechanical forces and hypoxia carried within the 3D structure. Our FPCL models displayed hallmark features, including ductal gland structures and differentiated CAFs with spindle shapes. Through morphological explorations alongside in-depth transcriptomic and metabolomic profiling, we identified substantial molecular shifts from the nascent to mature model stages and potential metabolic biomarkers, such as proline. The initial pharmacological assays highlighted the effectiveness of our FPCL model in screening for improved therapeutic strategies. In conclusion, our PDAC modeling platform mirrors complex tumor microenvironmental dynamics and offers an unparalleled perspective for therapeutic exploration.

18 January 2024 in Bone Marrow Transplantation
Verified
Journal Article
Closed access
PDF file
TSTakeshi Sugio
Takeshi Sugio
NUNaoyuki Uchida
Naoyuki Uchida
KMKohta Miyawaki
Kohta Miyawaki
YOYuju Ohno
Yuju Ohno
TETetsuya Eto
Tetsuya Eto
KKKoji Kato
Koji Kato